These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38448130)

  • 41. Current and future clinical applications of cardiac positron emission tomography.
    Ohira H; Mc Ardle B; Cocker MS; deKemp RA; Dasilva JN; Beanlands RS
    Circ J; 2013; 77(4):836-48. PubMed ID: 23486164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.
    Murthy VL; Bateman TM; Beanlands RS; Berman DS; Borges-Neto S; Chareonthaitawee P; Cerqueira MD; deKemp RA; DePuey EG; Dilsizian V; Dorbala S; Ficaro EP; Garcia EV; Gewirtz H; Heller GV; Lewin HC; Malhotra S; Mann A; Ruddy TD; Schindler TH; Schwartz RG; Slomka PJ; Soman P; Di Carli MF; Einstein A; Russell R; Corbett JR
    J Nucl Cardiol; 2018 Feb; 25(1):269-297. PubMed ID: 29243073
    [No Abstract]   [Full Text] [Related]  

  • 43. Current and Future Cardiovascular PET Radiopharmaceuticals.
    Al-Haddad R; Ismailani US; Rotstein BH
    PET Clin; 2019 Apr; 14(2):293-305. PubMed ID: 30826026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease.
    Heckmann MB; Reinhardt F; Finke D; Katus HA; Haberkorn U; Leuschner F; Lehmann LH
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010628. PubMed ID: 32912030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes.
    Guerraty MA; Rao HS; Anjan VY; Szapary H; Mankoff DA; Pryma DA; Rader DJ; Dubroff JG
    PLoS One; 2020; 15(2):e0228931. PubMed ID: 32053688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging to Stratify Coronary Artery Disease Risk in Asymptomatic Patients with Diabetes.
    Malahfji M; Mahmarian JJ
    Methodist Debakey Cardiovasc J; 2018; 14(4):266-272. PubMed ID: 30788012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantation.
    Nelson LM; Christensen TE; Rossing K; Hasbak P; Gustafsson F
    J Nucl Cardiol; 2022 Oct; 29(5):2555-2567. PubMed ID: 34414554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging Risk in Multisystem Inflammatory Diseases.
    Ikonomidis I; Makavos G; Katsimbri P; Boumpas DT; Parissis J; Iliodromitis E
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2517-2537. PubMed ID: 30878436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal Adenosine Stress for Maximum Stress Perfusion, Coronary Flow Reserve, and Pixel Distribution of Coronary Flow Capacity by Kolmogorov-Smirnov Analysis.
    Kitkungvan D; Lai D; Zhu H; Roby AE; Johnson NP; Steptoe DD; Patel MB; Kirkeeide R; Gould KL
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of myocardial blood flow and myocardial flow reserve by
    Tanada T; Ohba M; Kanezawa C; Suzuki K
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):195-199. PubMed ID: 36598684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
    Kitkungvan D; Bui L; Johnson NP; Patel MB; Roby AE; Vejpongsa P; Babar AK; Madjid M; Nacimbene A; Kumar S; DeGolovine A; Gould KL
    Eur Heart J Cardiovasc Imaging; 2019 Jul; 20(7):751-762. PubMed ID: 31056681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility of myocardial flow reserve prediction without the use of dynamic data from myocardial perfusion positron emission tomography.
    Hashimoto H; Fukushima Y; Kumita SI; Tomiyama T; Kiriyama T
    Int J Cardiovasc Imaging; 2018 Aug; 34(8):1323-1329. PubMed ID: 29556942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of modified coronary flow capacity by
    Miura S; Naya M; Kumamaru H; Ando A; Miyazaki C; Yamashita T
    J Cardiol; 2022 Feb; 79(2):247-256. PubMed ID: 34538532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applications of PET-MR Imaging in Cardiovascular Disorders.
    Cardoso R; Leucker TM
    PET Clin; 2020 Oct; 15(4):509-520. PubMed ID: 32888548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac
    Luong TV; Pedersen MGB; Kjærulff MLBG; Madsen S; Lauritsen KM; Tolbod LP; Søndergaard E; Gormsen LC
    Metabolism; 2021 Oct; 123():154862. PubMed ID: 34375646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial Perfusion Imaging Using Positron Emission Tomography.
    El-Tallawi KC; Aljizeeri A; Nabi F; Al-Mallah MH
    Methodist Debakey Cardiovasc J; 2020; 16(2):114-121. PubMed ID: 32670471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance.
    Mavrogeni S; Dimitroulas T; Bucciarelli-Ducci C; Ardoin S; Sfikakis PP; Kolovou G; Kitas GD
    Inflamm Allergy Drug Targets; 2014; 13(2):81-93. PubMed ID: 24479835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.
    Herzog BA; Husmann L; Valenta I; Gaemperli O; Siegrist PT; Tay FM; Burkhard N; Wyss CA; Kaufmann PA
    J Am Coll Cardiol; 2009 Jul; 54(2):150-6. PubMed ID: 19573732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced cardiac imaging, machine learning, and heart age for cardiovascular risk stratification.
    Siontis GC; Patel CJ
    Int J Cardiovasc Imaging; 2024 Jul; 40(7):1605-1606. PubMed ID: 38613603
    [No Abstract]   [Full Text] [Related]  

  • 60. Coronary artery lumen volume index as a marker of flow-limiting atherosclerosis-validation against
    Benetos G; Benz DC; Rampidis GP; Giannopoulos AA; von Felten E; Bakula A; Sustar A; Fuchs TA; Pazhenkottil AP; Gebhard C; Kaufmann PA; Gräni C; Buechel RR
    Eur Radiol; 2021 Jul; 31(7):5116-5126. PubMed ID: 33454800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.